Clinical Trial Imaging (Software And Services) By Technology (Echo, PET, MRI, X Ray, CT, Ultrasound And Other) Market For Biotech Companies, Pharmaceuticals, Research Center, Hospitals, And Other End-Users: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021

The report covers forecast and analysis for the clinical trial imaging market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based revenue (USD million). The study includes drivers and restraints for the market along with the impact they have on the demand over the forecast period. Additionally, the report includes study of opportunities available in the clinical trial imaging market on a global level.

In order to give the users of this report a comprehensive view on the clinical trial imaging market, we have included a detailed competitive scenario, and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the clinical trial imaging market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate and general attractiveness.

The study provides a decisive view on the clinical trial imaging market by segmenting the market based on product, technology, end user and region. Software and service are segments of product, where, Software is designed for clinical trial imaging. Services including operational imaging services, reader service, system and technology, design consulting. Various technologies in clinical imaging include echo, PET, MRI, x ray, CT, and ultrasound among others. MRI, CT, X-ray, ultrasound are the technologies having highest share in clinical trial imaging market. Different end users in this market are biotech companies, pharmaceuticals, research center, hospitals, diagnosis centers and others. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil.

The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. The key players of clinical trials imaging market include Cardiovascular Imaging Technologies, VirtualScopic, Biomedical Systems, BioClinica, Intrinsic Imaging LLC, Prism Clinical Imaging, PAREXEL International Corporation, and ICON among others.

This report segments the global clinical trial imaging market as follows:

Clinical Trials Imaging Market: Product Segment Analysis

• Service
• Software

Clinical Trials Imaging Market: Technology Segment Analysis

• X-ray
• CT
• MRI
• PET
• Echo
• Ultrasound
• Other technologies

Clinical Trials Imaging Market: End user Segment Analysis

• Biotech companies
• Pharmaceutical
• Research centers
• Hospitals
• Other end users

Clinical trial imaging Market: Regional Segment Analysis

• North America

  • US

• Europe

  • Germany
  • France
  • UK

• Asia Pacific

  • China
  • Japan
  • India

• Latin America

  • Brazil

• Middle East and Africa